What Tower Laboratories does

Tower Laboratories, Ltd. is a privately held U.S. contract manufacturer and private label supplier specializing exclusively in effervescent tablets, powders, and granulations. Founded in 1979 and headquartered in Centerbrook, Connecticut under Owner/President Norman Needleman, the company operates FDA-registered, cGMP-compliant facilities across Connecticut and Michigan, with more than 220,000 square feet of low-humidity manufacturing space producing over 2 billion effervescent tablets annually. Its core technology is the proprietary knowledge of low-humidity processing environments and effervescent formulation chemistry developed over more than 35 years, supplemented by in-house analytical laboratories (HPLC, AA, IR, UV/Vis) and a dedicated regulatory compliance function that supports OTC drugs, prescription drugs, medical devices, dietary supplements, cosmetics, and specialty applications.

Tower generates revenue through three interlocking streams: (1) contract manufacturing for pharmaceutical, nutraceutical, medical device, cosmetics, and beverage customers, with full-service product development from concept through commercialization on 9-18 month timelines; (2) National Brand Equivalent (NBE) private label products, including store-brand denture cleansers, antacid/pain relief, cold relief, and immune support tablets sold through direct relationships with top domestic retailers; and (3) Signature Formula dietary supplements and personal care products such as electrolyte tablets and stickpacks, calcium, vitamin C, urinary tract health stickpacks, and shower aromatherapy tablets. Pricing is quote-based and not publicly disclosed, development costs are often amortized into initial production runs, and customer agreements are structured as multi-year supply contracts.

Customer acquisition is primarily direct: a Business Development Director handles enterprise inquiries, and the company reaches its retail private-label accounts through direct selling relationships rather than broad marketing campaigns. The company is positioned as the leading U.S. supplier of store-brand effervescent products and operates entirely within the United States, with no disclosed international footprint, no external funding rounds, and no parent company.

Name

Tower Laboratories

Legal name

Tower Laboratories, Ltd.

Website

https://towerlabs.com

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

101–250 employees

Short description

Tower Laboratories is a privately held U.S. contract manufacturer and private label supplier specializing in effervescent tablets, powders, and granulations, serving pharmaceutical, nutraceutical, medical device, cosmetics, and beverage clients and top domestic retailers from FDA-registered, cGMP-compliant facilities in Connecticut and Michigan.

Ownership category

akta.pro rank

Product category

Effervescent Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA)

Keywords

• Effervescent contract manufacturing
• Private label supplements
• OTC drug manufacturing
• CGMP pharmaceutical production
• Effervescent tablet manufacturing

Headquarters

HQ city

Centerbrook

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Others, Marketing or Sales

Revenue model

1. Contract Manufacturing: Tower Laboratories provides full-service contract manufacturing for effervescent products including OTC drugs, prescription drugs, dietary supplements, medical devices, personal care products, and specialty applications. Development costs can sometimes be amortized into costs for initial production runs depending on volumes.
2. Private Label Products: National Brand Equivalent (NBE) store-brand products including denture cleansers, antacid/pain relief, cold relief, and immune support tablets sold to major domestic retailers.
3. Product Development Services: Effervescent product development from concept through commercialization. Typical development timelines run from 9 to 18 months including prototype development, optimization, line trials, validation and formal stability testing. Development costs vary significantly and can be amortized into initial production costs.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Tower Laboratories is a U.S.-based contract manufacturer specializing in effervescent tablets, powders, and granulations for the OTC drug, prescription drug, dietary supplement, medical device, personal care, cosmetic, and beverage markets. The company operates FDA-registered, cGMP-compliant facilities producing more than 2 billion effervescent tablets annually across 220,000+ square feet of manufacturing space, and offers end-to-end services spanning product development, analytical testing, regulatory filing, packaging, and private label / store-brand supply for retailer and brand-owner customers.

Product overview

Tower Laboratories is a contract effervescent manufacturing company offering a comprehensive portfolio of products and services. The company operates two distinct product lines: (1) National Brand Equivalent (NBE) store-brand products including denture cleansers (Efferdent, Polident), antacid/pain relief tablets (Alka Seltzer equivalents), cold relief tablets (Alka Seltzer Plus equivalents), and immune support tablets (Airborne equivalents); and (2) Signature Formula offerings including dietary supplements (electrolyte tablets and stickpacks, calcium tablets, vitamin C tablets, urinary tract health stickpacks), over-the-counter drugs, and cosmetic products (shower aromatherapy tablets). The company also provides full-service contract manufacturing including effervescent tablets, powders, and granulations (over 2 billion tablets annually), in-house quality control and regulatory compliance support, product development services (concept through commercialization), and packaging solutions (strips, pouches, stick packs, tubes).

Differentiator

Problem solved

Functional benefit

Products and services

• Private Label (National Brand Equivalent) Store-Brand Effervescent Products
• Signature Formula Effervescent Dietary Supplements
• Signature Formula OTC Effervescent Drug Products
• Signature Formula Effervescent Personal Care Products
• Contract Effervescent Manufacturing Services
• Effervescent Cosmetics & Beverage Manufacturing
• Effervescent Product Development Services
• In-House Analytical Testing & Quality Control Services
• Regulatory Filing & Compliance Support Services
• Effervescent Packaging Solutions

Quantifiable outcome

• 2+ billion effervescent tablets produced annually
• +1 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Bausch Health Companies: Bausch Health operates a diversified consumer health and specialty pharma portfolio including OTC and dental care brands that overlap categories Tower supplies on a private-label basis. As a broad incumbent, Bausch provides a reference point for how larger diversified health companies compete in adjacencies to Tower's NBE categories.
• Thermo Fisher Scientific (Patheon): Thermo Fisher's Patheon division operates one of the largest global CDMO networks for oral solid dosage forms, including specialty formats, and competes with Tower for pharmaceutical contract manufacturing programs. As a broad incumbent, it represents the scale tier Tower would face when bidding for large, multi-region brand-owner contracts.
• Haleon plc: Haleon owns global OTC and oral health brands (Centrum, Panadol, Advil, Voltaren and formerly Alka-Seltzer in some markets) and competes with Tower's customers through branded effervescent SKUs. As a much larger diversified consumer health company, Haleon is a broad incumbent whose branded portfolio sets the benchmark Tower's NBE products replicate.
• Bayer AG: Bayer currently owns the Alka-Seltzer brand globally — the marquee branded effervescent SKU that Tower's NBE franchise effectively replicates for private-label retailers. Bayer's Consumer Health division provides a reference point for global scale, branded pricing, and format leadership in effervescence.

Direct peers

• Prestige Consumer Healthcare: Prestige markets and manufactures OTC consumer health products across categories including dental, gastrointestinal, and analgesics, several of which Tower manufactures on a private-label basis. The overlap in product categories and retail-channel go-to-market makes Prestige a direct business-model peer.
• Perrigo Company plc: Perrigo is the largest U.S. store-brand OTC pharmaceutical and consumer health manufacturer, producing private-label equivalents across categories that directly overlap with Tower's NBE franchise in antacids, cold relief, and dietary supplements. Like Tower, Perrigo supplies major domestic retailers with high-volume, cGMP-compliant formulations, making it the most direct comparability anchor.
• Hermes Arzneimittel GmbH: Hermes Arzneimittel is a German pharmaceutical company historically known for effervescent products (e.g., Biolectra, Magnesium-Diasporal) and operates cGMP manufacturing of effervescent dosage forms. It is one of the closest format-specialist peers to Tower outside the U.S., offering a direct comparability on effervescent-focused manufacturing expertise.
• Catalent, Inc. Catalent is one of the largest global pharmaceutical contract development and manufacturing organizations, with cGMP soft-gel, oral solid, and specialty dose form capabilities that overlap Tower's contract manufacturing model. While Catalent does not specialize in effervescence, it competes for the same contract manufacturing wallet and is a key scale benchmark for specialty CDMOs.

Emerging players

• AdvaCare Pharma: AdvaCare Pharma is a global manufacturer and distributor of pharmaceuticals, supplements, and medical devices with effervescent tablet capabilities targeting both branded and private-label customers. It is comparable as an emerging effervescent and supplement manufacturer pursuing global private-label customers, though at smaller and more fragmented scale than Tower.

Regional players

• Eurofarma Laboratórios: Eurofarma is one of the largest Brazilian pharmaceutical manufacturers with a strong portfolio of effervescent and orally disintegrating products across Latin America. It is comparable to Tower as a regionally dominant effervescent-focused manufacturer but operates primarily in South America rather than competing head-to-head in the U.S.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/tower-laboratories-ltd.

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tower Laboratories